These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32320807)

  • 1. Chitosan mediated 5-Fluorouracil functionalized silica nanoparticle from rice husk for anticancer activity.
    Dhinasekaran D; Raj R; Rajendran AR; Purushothaman B; Subramanian B; Prakasarao A; Singaravelu G
    Int J Biol Macromol; 2020 Aug; 156():969-980. PubMed ID: 32320807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing therapeutic efficacy: sustained delivery of 5-fluorouracil (5-FU) via thiolated chitosan nanoparticles targeting CD44 in triple-negative breast cancer.
    Anjum S; Naseer F; Ahmad T; Jahan F; Qadir H; Gul R; Kousar K; Sarwar A; Shabbir A
    Sci Rep; 2024 May; 14(1):11431. PubMed ID: 38763930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galactosylated Chitosan-Functionalized Mesoporous Silica Nanoparticle Loading by Calcium Leucovorin for Colon Cancer Cell-Targeted Drug Delivery.
    Liu W; Wang F; Zhu Y; Li X; Liu X; Pang J; Pan W
    Molecules; 2018 Nov; 23(12):. PubMed ID: 30486276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and in-vitro evaluation of mesoporous biogenic silica nanoparticles obtained from rice and wheat husk as a biocompatible carrier for anti-cancer drug delivery.
    Porrang S; Rahemi N; Davaran S; Mahdavi M; Hassanzadeh B
    Eur J Pharm Sci; 2021 Aug; 163():105866. PubMed ID: 33957220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ball milling synthesis of silica nanoparticle from rice husk ash for drug delivery application.
    Salavati-Niasari M; Javidi J; Dadkhah M
    Comb Chem High Throughput Screen; 2013 Jul; 16(6):458-62. PubMed ID: 22931308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wheat germ agglutinin-conjugated chitosan-Ca-alginate microparticles for local colon delivery of 5-FU: development and in vitro characterization.
    Glavas Dodov M; Calis S; Crcarevska MS; Geskovski N; Petrovska V; Goracinova K
    Int J Pharm; 2009 Nov; 381(2):166-75. PubMed ID: 19580856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-Cysteine conjugated poly L-lactide nanoparticles containing 5-fluorouracil: formulation, characterization, release and uptake by tissues in vivo.
    Mishra BJ; Kaul A; Trivedi P
    Drug Deliv; 2015 Feb; 22(2):214-22. PubMed ID: 24524408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-flourouracil loaded N,O-carboxymethyl chitosan nanoparticles as an anticancer nanomedicine for breast cancer.
    Anitha A; Chennazhi KP; Nair SV; Jayakumar R
    J Biomed Nanotechnol; 2012 Feb; 8(1):29-42. PubMed ID: 22515092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan-glucuronic acid conjugate coated mesoporous silica nanoparticles: A smart pH-responsive and receptor-targeted system for colorectal cancer therapy.
    Narayan R; Gadag S; Cheruku SP; Raichur AM; Day CM; Garg S; Manandhar S; Pai KSR; Suresh A; Mehta CH; Nayak Y; Kumar N; Nayak UY
    Carbohydr Polym; 2021 Jun; 261():117893. PubMed ID: 33766378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytocompatible chitosan-graft-mPEG-based 5-fluorouracil-loaded polymeric nanoparticles for tumor-targeted drug delivery.
    Antoniraj MG; Ayyavu M; Henry LJK; Nageshwar Rao G; Natesan S; Sundar DS; Kandasamy R
    Drug Dev Ind Pharm; 2018 Mar; 44(3):365-376. PubMed ID: 28835136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fabrication of high specificity hollow mesoporous silica nanoparticles assisted by Eudragit for targeted drug delivery.
    She X; Chen L; Velleman L; Li C; Zhu H; He C; Wang T; Shigdar S; Duan W; Kong L
    J Colloid Interface Sci; 2015 May; 445():151-160. PubMed ID: 25617610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles.
    Rajan M; Raj V; Al-Arfaj AA; Murugan AM
    Int J Pharm; 2013 Sep; 453(2):514-22. PubMed ID: 23796828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan-capped mesoporous silica nanoparticles as pH-responsive nanocarriers for controlled drug release.
    Hu X; Wang Y; Peng B
    Chem Asian J; 2014 Jan; 9(1):319-27. PubMed ID: 24115568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of Biotin-Modified Galactosylated Chitosan Nanoparticles and Their Characteristics in Vitro and in Vivo.
    Cheng M; Ma D; Zhi K; Liu B; Zhu W
    Cell Physiol Biochem; 2018; 50(2):569-584. PubMed ID: 30308481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and characterization of silica nanoparticles from rice ashes coated with chitosan/cancer cell membrane for hepatocellular cancer treatment.
    Espinoza MJC; Lin KS; Weng MT; Kunene SC; Lin YS; Lin YT
    Int J Biol Macromol; 2023 Feb; 228():487-497. PubMed ID: 36581030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functionalization of rice husk-derived mesoporous silica nanoparticles for targeted and imaging in cancer drug delivery.
    Chen SY; Jian JY; Lin HM
    J Sci Food Agric; 2024 Mar; 104(4):2120-2129. PubMed ID: 38009620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells.
    Cheng M; Xu H; Wang Y; Chen H; He B; Gao X; Li Y; Han J; Zhang Z
    Drug Des Devel Ther; 2013; 7():1287-99. PubMed ID: 24187487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoporous Silica Nanoparticles Coated with Carboxymethyl Chitosan for 5-Fluorouracil Ocular Delivery: Characterization, In Vitro and In Vivo Studies.
    Alhowyan AA; Kalam MA; Iqbal M; Raish M; El-Toni AM; Alkholief M; Almomen AA; Alshamsan A
    Molecules; 2023 Jan; 28(3):. PubMed ID: 36770926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aerosol-Assisted Synthesis of Tailor-Made Hollow Mesoporous Silica Microspheres for Controlled Release of Antibacterial and Anticancer Agents.
    Poostforooshan J; Belbekhouche S; Shaban M; Alphonse V; Habert D; Bousserrhine N; Courty J; Weber AP
    ACS Appl Mater Interfaces; 2020 Feb; 12(6):6885-6898. PubMed ID: 31967774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. pH-responsive chitosan-mediated spherical mesoporous silica microspheres for high loading and controlled delivery of 5-Fluorouracil.
    Zhang Q; Wan T; Jin G; Xu S
    Carbohydr Res; 2024 Sep; 543():109206. PubMed ID: 39002209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.